|
HY-W052006-100mg
|
MedChemexpress LLC
|
m-PEG7-thiol [CAS 651042-82-9]
|
|
Cancer-programmed cell death
|
|
|
HY-W052006-50mg
|
MedChemexpress LLC
|
m-PEG7-thiol [CAS 651042-82-9]
|
|
Cancer-programmed cell death
|
|
|
HY-W052006-500mg
|
MedChemexpress LLC
|
m-PEG7-thiol [CAS 651042-82-9]
|
|
Cancer-programmed cell death
|
|
|
HY-W040236-100mg
|
MedChemexpress LLC
|
m-PEG8-Amine [CAS 869718-81-0]
|
|
Cancer-programmed cell death
|
|
|
HY-W040236-50mg
|
MedChemexpress LLC
|
m-PEG8-Amine [CAS 869718-81-0]
|
|
Cancer-programmed cell death
|
|
|
HY-W040236-500mg
|
MedChemexpress LLC
|
m-PEG8-Amine [CAS 869718-81-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130148-100mg
|
MedChemexpress LLC
|
m-PEG8-Br [CAS 1056881-04-9]
|
|
Cancer-programmed cell death
|
|
|
HY-130148-250mg
|
MedChemexpress LLC
|
m-PEG8-Br [CAS 1056881-04-9]
|
|
Cancer-programmed cell death
|
|
|
HY-130148-50mg
|
MedChemexpress LLC
|
m-PEG8-Br [CAS 1056881-04-9]
|
|
Cancer-programmed cell death
|
|
|
HY-130145-100mg
|
MedChemexpress LLC
|
m-PEG8-CH2COOH [CAS 102013-72-9]
|
|
Cancer-programmed cell death
|
|
|
HY-130145-250mg
|
MedChemexpress LLC
|
m-PEG8-CH2COOH [CAS 102013-72-9]
|
|
Cancer-programmed cell death
|
|
|
HY-130145-50mg
|
MedChemexpress LLC
|
m-PEG8-CH2COOH [CAS 102013-72-9]
|
|
Cancer-programmed cell death
|
|
|
HY-W019793-100mg
|
MedChemexpress LLC
|
m-PEG8-NHS ester [CAS 756525-90-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-W019793-50mg
|
MedChemexpress LLC
|
m-PEG8-NHS ester [CAS 756525-90-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-135932-100mg
|
MedChemexpress LLC
|
m-PEG8-O-alkyne [CAS 880081-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-135932-25mg
|
MedChemexpress LLC
|
m-PEG8-O-alkyne [CAS 880081-81-2]
|
|
Cancer-programmed cell death
|
|
